Anti-(human Complement C5)(humanized Ro7112689 Heavy Chain)

Anti-(human Complement C5)(humanized Ro7112689 Heavy Chain) Uses, Dosage, Side Effects, Food Interaction and all others data.

Anti-(human Complement C5)(humanized Ro7112689 Heavy Chain) is under investigation in clinical trial NCT03157635 (Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Anti-(human Complement C5)(humanized Ro7112689 Heavy Chain) in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria).

Trade Name	Anti-(human Complement C5)(humanized Ro7112689 Heavy Chain)
Generic	Crovalimab
Crovalimab Other Names	Complement c5 inhibitory humanized recycling monoclonal antibody (rg-6107 ), Crovalimab, Immunoglobulin g1, anti-(human complement c5)(humanized ro7112689 heavy chain), disulfide with humanized ro7112689 light chain, dimer
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Innovators Monograph

You find simplified version here Anti-(human Complement C5)(humanized Ro7112689 Heavy Chain)